Alfonso Berrocal
Hospital General Universitario De Valencia(ES)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Glioma Diagnosis and Treatment
Most-Cited Works
- → Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study(2018)1,656 cited
- → A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer(2013)349 cited
- → Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination(2022)124 cited
- → Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR(2015)114 cited
- → Management of high-risk and advanced basal cell carcinoma(2015)104 cited
- → Immune checkpoint inhibitors: therapeutic advances in melanoma.(2015)82 cited
- → Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC)(2009)69 cited
- → Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial(2016)55 cited
- → Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study(2020)52 cited
- → Melanoma: Diagnosis, Staging, and Treatment. Consensus group recommendations(2014)42 cited